Encore Medical Corporation to Present at the 26th Annual SG Cowen Health Care Conference
01 Marzo 2006 - 6:00AM
PR Newswire (US)
AUSTIN, Texas, March 1 /PRNewswire-FirstCall/ -- Encore Medical
Corporation (NASDAQ:ENMC) announced today that Kenneth W. Davidson,
CEO and Chairman of the Board of Directors, and other members of
Encore's Executive Management, will present at the 26th Annual SG
Cowen Health Care Conference on Tuesday, March 7, 2006 at 11:20a.m.
EST. The conference is being held at The Marriott Copley Place in
Boston. The presentation will provide an overview of Encore's
products, market opportunities and competitive position. A live
webcast of the presentation can be accessed at the Company's
website: http://www.encoremed.com/ . The replay will be available
approximately one hour after the presentation and will be archived
until May 1, 2006. Encore Medical Corporation is a diversified
orthopedic device company that develops, manufactures and
distributes a comprehensive range of high quality orthopedic
devices used by orthopedic surgeons, physicians, therapists,
athletic trainers and other healthcare professionals to treat
patients with musculoskeletal conditions resulting from
degenerative diseases, deformities, traumatic events and
sports-related injuries. Through its Orthopedic Rehabilitation
Division, Encore is a leading distributor of electrical stimulation
and other orthopedic products used for pain management, orthopedic
rehabilitation, physical therapy, fitness and sport performance
enhancement. Encore's Surgical Implant Division offers a
comprehensive suite of reconstructive joint products and spinal
implants. For more information, visit http://www.encoremed.com/ .
Contact Davis Henley, Vice President - Business Development (512)
832-9500 Except for the historical information contained herein,
the matters discussed are forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. These statements involve risks and
uncertainties, such as quarterly fluctuations in operating results,
the timely availability of new products, the impacts of competitive
products and pricing, the ability to grow the distribution networks
for the Company's products, the ability to continue to obtain long-
term financing, and the ability to locate and integrate future
acquisitions and other risks and uncertainties set forth in the
Company's filings with the Securities and Exchange Commission.
These risks and uncertainties could cause actual results to differ
materially from any forward-looking statements made herein.
DATASOURCE: Encore Medical Corporation CONTACT: Davis Henley, Vice
President - Business Development of Encore Medical Corporation,
+1-512-832-9500, or Web site: http://www.encoremed.com/
Copyright
Encore Medical (NASDAQ:ENMC)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Encore Medical (NASDAQ:ENMC)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024
Real-Time news about Encore Medical (NASDAQ): 0 recent articles
Más de Encore Medical (MM) Artículos de Noticias